Tharimmune, Inc.

Tharimmune, Inc.verified

THAR

Price:

$3.54

Market Cap:

$109.42M

Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic diseases. The company's pre-clinical immuno-oncology pipeline includes TH104, a product candidate for the treatment of liver-related and other pruritogenic inflammatory conditions; TH3215 and TH0059 that are product candidates used to treat various solid tumors; and TH1940, which targets programmed cell death protein 1 (PD-1). It has a research collaboration and product license agreement with Minotaur Therapeutics, Inc. for the development of proprietary targeted biologics. The company was formerly known as Hillstream BioPharma, Inc. and changed...[Read more]

Industry

Biotechnology

IPO Date

2022-01-12

Stock Exchange

NASDAQ

Ticker

THAR

The Enterprise Value as of April 2026 (TTM) for Tharimmune, Inc. (THAR) is 92.39M

According to Tharimmune, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 92.39M. This represents a change of 283.04% compared to the average of 24.12M of the last 4 quarters.

Tharimmune, Inc. (THAR) Historical Enterprise Value (quarterly & annually)

How has THAR Enterprise Value performed in the past?

The mean historical Enterprise Value of Tharimmune, Inc. over the last ten years is 26.10M. The current 92.39M Enterprise Value has changed 35.29% with respect to the historical average. Over the past ten years (40 quarters), THAR's Enterprise Value was at its highest in in the December 2025 quarter at 80.08M. The Enterprise Value was at its lowest in in the December 2023 quarter at -4955944.20.

Quarterly (TTM)
Annual

Average

26.10M

Median

36.75M

Minimum

-10270450.44

Maximum

80.08M

Tharimmune, Inc. (THAR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Tharimmune, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 389.28%

Maximum Annual Enterprise Value = 80.08M

Minimum Annual Increase = -8729.95%

Minimum Annual Enterprise Value = -10270450.44

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202580.08M-8729.95%
2024-927892.30-90.97%
2023-10270450.44389.28%
2022-2099113.96-105.03%
202141.71M11.27%
202037.49M2.00%

Tharimmune, Inc. (THAR) Average Enterprise Value

How has THAR Enterprise Value performed in the past?

The current Enterprise Value of Tharimmune, Inc. (THAR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

22.96M

5-year avg

21.70M

10-year avg

26.10M

Tharimmune, Inc. (THAR) Enterprise Value vs. Peers

How is THAR’s Enterprise Value compared to its peers?

Tharimmune, Inc.’s Enterprise Value is greater than BioLineRx Ltd. (20.10M), greater than GeoVax Labs, Inc. (-2242569993608.00), less than Adlai Nortye Ltd. (750.49M), greater than Lunai Bioworks Inc. (8.40M), greater than SeaStar Medical Holding Corporation (-663520.00), greater than Adaptimmune Therapeutics plc (23.77M), greater than Ainos, Inc. (17.95M), greater than Apollomics, Inc. (11.79M), greater than Aditxt, Inc. (-192070417.00), greater than Moleculin Biotech, Inc. (-5484109.00),

CompanyEnterprise ValueMarket cap
20.10M$13.36M
-2242569993608.00$1.01M
750.49M$747.90M
8.40M$5.92M
-663520.00$10.79M
23.77M$75.16M
17.95M$7.36M
11.79M$14.43M
-192070417.00$583.00
-5484109.00$3.03M

Build a custom stock screener for Tharimmune, Inc. (THAR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tharimmune, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tharimmune, Inc. (THAR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tharimmune, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Tharimmune, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Tharimmune, Inc. (THAR)?

What is the 3-year average Enterprise Value for Tharimmune, Inc. (THAR)?

What is the 5-year average Enterprise Value for Tharimmune, Inc. (THAR)?

How does the current Enterprise Value for Tharimmune, Inc. (THAR) compare to its historical average?